AdvertisementDoctors Encouraged By Antibody Treatments For COVID-19January 06, 2021Richard HarrisfacebookEmailNurse Janet Gilleran prepares to treat COVID-19 patient Mike Mokler with bamlanivimab, a monoclonal antibody drug from Eli Lilly, at the Respiratory Infection Clinic of Tufts Medical Center in Boston on Dec. 31, 2020. (Boston Globe via Getty Images)
